The significant overexpression of STAT1 (Figure 8c) indicates that fludarabine’s tumor selectivity is associated with its regulatory influence on inhibiting STAT1 function and malignant metabolic activity, and it is clinically relevant. The gene discussed is STAT1; the disease is neoplasm.